Lupus drug showdown: which works better?
NCT ID NCT07053137
First seen Feb 02, 2026 · Last updated Jun 08, 2026 · Updated 21 times
Summary
This study looks back at medical records of 180 adults with lupus to compare two drugs, telitacicept and belimumab. The goal is to see which one works better at controlling the disease and has fewer side effects. Participants were already taking one of these drugs for at least 12 weeks, and the study analyzes their outcomes without giving any new treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Qianfoshan Hospital
Jinan, Shandong, 250000, China
Conditions
Explore the condition pages connected to this study.